GLICLAZIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H21N3O3S
Molecular Weight	323.411
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of GLICLAZIDE

Structure Search

SMILES

[H][C@@]12CCC[C@]1([H])CN(C2)NC(=O)NS(=O)(=O)C3=CC=C(C)C=C3

InChI

InChIKey=BOVGTQGAOIONJV-BETUJISGSA-N

InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+

HIDE SMILES / InChI

Molecular Formula	C15H21N3O3S
Molecular Weight	323.411
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 19:15:33 UTC 2023` Edited by `admin` on `Fri Dec 15 19:15:33 UTC 2023`
Record UNII	G4PX8C4HKV
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GLICLAZIDE

Official Name

English

SE 1702

Code

English

BENZENESULFONAMIDE, N-(((HEXAHYDROCYCLOPENTA(C)PYRROL-2(1H)-YL)AMINO)CARBONYL)-4-METHYL-

Systematic Name

English

SE-1702

Code

English

gliclazide [INN]

Common Name

English

GLICLAZIDE [MI]

Common Name

English

J3.151H

Code

English

Gliclazide [WHO-DD]

Common Name

English

S-1702

Code

English

NSC-758673

Code

English

GLICLAZIDE [EP MONOGRAPH]

Common Name

English

S-852

Code

English

DIAMICRON

Brand Name

English

GLICLAZIDE [JAN]

Common Name

English

1-(3-AZABICYCLO(3.3.0)OCT-3-YL)-3-(P-TOLYLSULFONYL)UREA

Common Name

English

GLIMICRON

Brand Name

English

GLICLAZIDE [MART.]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C97936

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

WHO-VATC

QA10BB09

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

WHO-ATC

A10BB09

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

Code System Code Type Description

ECHA (EC/EINECS)

244-260-5

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

FDA UNII

G4PX8C4HKV

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

MESH

D005907

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

EVMPD

SUB07921MIG

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

PUBCHEM

667431

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

DRUG CENTRAL

1299

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

WIKIPEDIA

GLICLAZIDE

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

RXCUI

4816

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

RxNorm

NCI_THESAURUS

C87618

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

EPA CompTox

DTXSID9023095

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

CAS

21187-98-4

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

SMS_ID

100000090151

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

NSC

758673

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

CHEBI

31654

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

DRUG BANK

DB01120

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

INN

3056

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

MERCK INDEX

m5744

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

Merck Index

ChEMBL

CHEMBL427216

Created by admin on Fri Dec 15 19:15:33 UTC 2023 , Edited by admin on Fri Dec 15 19:15:33 UTC 2023

PRIMARY

Related Record Type Details


					AIN96D6SGL

OATP1B1

TRANSPORTER -> SUBSTRATE

Comments:

Compared with the OATP1B1*1a, mutants OATP1B1*5 and OATP1B1*15 showed significantly decreased transport capacity.

Amount:


					8RT5G5EY5Z

ATP-BINDING CASSETTE SUB-FAMILY C MEMBER 8

TARGET -> INHIBITOR

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> SUBSTRATE

Comments:

Clearance of gliclazide in CYP2C9*2 and *3 was significantly reduced compared to the wild-type.

Amount:

Related Record Type Details


					76FTS44XK2

Carboxy Gliclazide

METABOLITE -> PARENT

Amount:


					22WWT9N6C3

Hydroxy Gliclazide

METABOLITE -> PARENT

Amount:

Related Record Type Details


					I8266RI90M

P-TOLUENESULFONAMIDE

IMPURITY -> PARENT

Amount:


					P83946FTE5

Ethyl tosylcarbamate

IMPURITY -> PARENT

Amount:


					SWM78SDK2G

rel-4-Methyl-N-[[[(3aR,6aS)-3,3a,4,6a-tetrahydrocyclopenta[c]pyrrol-2(1H)-yl]amino]carbonyl]benzenesulfonamide

IMPURITY -> PARENT

Amount:


					88P67223SH

Hexahydro-N-[(4-methylphenyl)sulfonyl]cyclopenta[c]pyrrole-2(1H)-carboxamide

IMPURITY -> PARENT

Amount:

Related Record Type Details


					G4PX8C4HKV

ACTIVE MOIETY

Amount: